News Industry News FDA Advisory Committee Votes Favorably on Abbott's Minimally Invasive MitraClip® Device for Patients with Significant Mitral Regurgitation Who Are Too High Risk for Surgery March 20, 2013
News Industry News Abbott's Minimally Invasive MitraClip® System for Mitral Regurgitation Demonstrates Positive Clinical and Quality- of-Life Results for Patients Too High Risk for Surgery March 09, 2013
News Industry News Abbott Reinforces Global Vascular Leadership with New Data on Innovative Technologies at ACC 2012 March 20, 2012
News Industry News Data from Landmark Clinical Trial of Abbott's MitraClip® System Demonstrate Durable Clinical Benefits for Patients with Mitral Regurgitation Two Years After Treatment April 04, 2011
News Industry News Abbott to Present Data on Novel Vascular Technologies and XIENCE V® at ACC 2011 March 28, 2011